Archives

by in
Entry Author Date Location
West Coast Biotech Roundup: Genentech, CareDx, and More 07/17/14 San Diego
With New Calendar App, Owaves Takes First Step to Healthy Lifestyle 05/13/14 San Diego
Rhythm Eyes Pivotal Study as GI Drug for Diabetics Hits Phase 2 Mark 05/06/14 Boston
How A Kidney Drug Almost Torpedoed Concert Pharma’s IPO 04/25/14 Boston
Myriad RBM Test Helping to Mine Secrets of Normal Immune System 04/16/14 Texas
Backed By a Billionaire, Berg Pharma Aims to Speed Drugmaking 04/02/14 Boston
Celladon Could Go Far Under Servier Collaboration, Licensing Deal 02/25/14 San Diego
East Coast Biotech Roundup: Curoverse, Sia, Trinity, & (Much) More 12/20/13 Boston
San Diego Life Sciences Roundup: Orexigen, Avalon, GSK, and More 11/27/13 San Diego
San Diego Life Sciences Roundup: Tandem, Sorrento, Volcano, & More 11/14/13 San Diego
Tandem Diabetes Care Raises $120M in Bigger-Than-Expected IPO 11/13/13 San Diego
San Diego Life Sciences Roundup: Santarus, Cytori, IPOs, and More 11/08/13 San Diego
San Diego Life Sciences Roundup: Illumina, Mirati, Auspex, and More 10/25/13 San Diego
San Diego Life Sciences Roundup: Evoke Pharma, Isis, Otonomy, & More 09/06/13 San Diego
San Diego Life Sciences Roundup: Orexigen, Volcano, MediciNova, & More 08/30/13 San Diego
Glooko Helps Patients Manage Diabetes Digitally 08/28/13 San Francisco
Array Biopharma Cuts Staff by 20%, Loses Development Deal with Amgen 08/07/13 Boulder/Denver
Freedom Meditech Raises $7M to Market New Diabetes Screening Device 08/06/13 San Diego
ViaCyte Raises $10.6M as Artificial Pancreas Moves Toward Key Trials 07/10/13 San Diego
GI Dynamics Lines Up $52M For Key U.S. Study 07/03/13 Boston
San Diego Life Sciences Roundup: Isis, Elcelyx, Acutus, and More 06/27/13 San Diego
Zafgen’s Obesity Drug Continues to Cut The Fat in Phase 2 Trial 06/22/13 Boston
Abide Therapeutics and Merck Unveil Diabetes Drug Collaboration 05/02/13 San Diego
U-M Spinout Diapin Therapeutics Attracts Chinese Investment 03/14/13 Detroit
GlaxoSmithKline Shuts Down Sirtris, Five Years After $720M Buyout 03/12/13 Boston
Sanitas Gets FDA Clearance to Market ‘Wellaho’ for Chronically Ill 02/20/13 San Diego
Elcelyx Closes on $20M to Advance Appetite-Control Compounds 02/14/13 San Diego
Pfizer Invests in Rhythm to Support Diabetes, Obesity Drug Programs 11/27/12 Boston
Stanford’s Mike Snyder is Showing the Way With Personalized Medicine 11/19/12 National
San Diego Life Sciences Roundup: Shire, Thesan, ViaCyte, and More 11/02/12 San Diego
Page 1 of 11 next page »